Pharmacokinetics of Olverembatinib in Participants With Hepatic Impairment

Clinical trial NCT07282093 · RECRUITING

Trial details

NCT number: NCT07282093
Sponsor: Ascentage Pharma Group Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetic Olverembatinib

Start date: 2025-11-11
Primary completion: 2026-06-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.